Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 06-2011 | 06-2010 | 06-2009 | 06-2008 | |
| Sales | 52,610 | 38,858 | 31,485 | 48,876 | 61,635 |
| Cost of Goods | 27,872 | 20,138 | 15,942 | 24,756 | 33,164 |
| Gross Profit | 24,738 | 18,720 | 15,543 | 24,120 | 28,471 |
| Operating Expenses | 16,372 | 11,164 | 9,595 | 9,784 | 8,664 |
| Operating Income | 9,238 | 7,694 | 6,890 | 15,092 | 19,971 |
| Other Income | -4,361 | 281 | 414 | 432 | 191 |
| Pre-tax Income | 4,877 | 7,975 | 7,304 | 15,524 | 20,162 |
| Income Tax | 2,895 | 2,448 | 2,350 | 5,023 | 6,453 |
| Net Income Continuous | 1,982 | 5,527 | 4,954 | 10,501 | 13,709 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 860 |
| Net Income | $1,982 | $5,527 | $4,954 | $10,501 | $14,569 |
| EPS Basic Total Ops | 0.23 | 0.65 | 0.58 | 1.22 | 1.70 |
| EPS Basic Continuous Ops | 0.23 | 0.65 | 0.58 | 1.22 | 1.60 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.10 |
| EPS Diluted Total Ops | 0.23 | 0.65 | 0.58 | 1.22 | 1.70 |
| EPS Diluted Continuous Ops | 0.23 | 0.65 | 0.58 | 1.22 | 1.60 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.10 |
| EPS Diluted Before Non-Recurring Items | 0.75 | 0.65 | 0.58 | 1.22 | N/A |
| EBITDA(a) | $10,866 | $8,913 | $7,597 | $15,858 | $20,638 |